Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Children's Hospital of Philadelphia
With
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
The investigators will conduct a single-center Phase II randomized clinical trial in which adolescents ages 14-23 and greater 3 months post solid organ transplant will receive either a peer mentor or usual care. The investigators will assess changes in quality of life from baseline to one year post-study entry. The investigators will also examine adherence changes over the same time frame using pharmacy refill data and a questionnaire. Peer mentors will provide social support and promote subject self-efficacy primarily via e-communication. Changes in social support and self-efficacy will be measured over a one-year period.
Age
14–23
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Males or females age 14 to 23 years
Greater than one year post kidney, heart or liver transplant
Able to speak and read in English
Willing and able to provide informed consent or assent
Parental guardian permission (informed consent) if appropriate
You may not be if
Unwilling to participate
Unable to speak or read in English
Unable to provide informed assent or consent
Estimated glomerular filtration rate (eGFR) less than 20 ml/min/1.73m\^2
On dialysis
Less than three months post transplant
Post-transplant lymphoproliferative disease
Clareo Health | Peers for Promoting Adolescent Transplant Health
